Literature DB >> 2102284

Risk of subsequent cytological abnormality and cancer among women with a history of cervical intraepithelial neoplasia: a comparative study.

H Mitchell1, G Medley, J B Carlin.   

Abstract

A longitudinal study of 1,281 women with a histological diagnosis of cervical intraepithelial neoplasia (CIN) during 1974-76 is presented. After 12 years of follow-up, 30 percent of the women had further cytological abnormalities reported. The rate of subsequent abnormality was highest during the first 12 months of follow-up; thereafter, there was no evidence of any decline in the rate of subsequent abnormality with increasing duration of follow-up. Women from the CIN cohort had twice as many later cytological abnormalities as an age-matched cohort of women who were negatively screened during 1974-76 (excluding abnormalities within 12 months of entry to the study and after adjustment for smear frequency). The CIN cohort remained at substantially greater risk for a subsequent diagnosis of squamous cell carcinoma of the cervix compared with the control group of negatively-screened women (rate ratio 19.8, 95 percent confidence interval 2.4-163.6, P less than 0.01). These results indicate that women who have received surgical intervention for CIN continue to have substantial morbidity from cervical abnormalities during medium-term follow-up.

Entities:  

Mesh:

Year:  1990        PMID: 2102284     DOI: 10.1007/bf00053165

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  14 in total

1.  Age and time trends in the prevalence of cervical intraepithelial neoplasia on Papanicolaou smear tests, 1970-1988.

Authors:  H Mitchell; G Medley
Journal:  Med J Aust       Date:  1990-03-05       Impact factor: 7.738

2.  Electrocoagulation diathermy for the treatment of cervical dysplasia and carcinoma in situ.

Authors:  V E Hollyock; W Chanen
Journal:  Obstet Gynecol       Date:  1976-02       Impact factor: 7.661

3.  Changing cytologic detection rates for cervical intraepithelial neoplasia and invasive cancer in a population lacking a mass screening program.

Authors:  E Frangopoulou; A Linos; P Mentzelopoulou; M Papaefthimiou; M Efstratiadou
Journal:  Acta Cytol       Date:  1989 Nov-Dec       Impact factor: 2.319

4.  Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on evaluation of cervical cancer screening programmes.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-13

5.  Reasons that some screening programmes fail to control cervical cancer.

Authors:  J Chamberlain
Journal:  IARC Sci Publ       Date:  1986

6.  Prospective evaluation of risk of cervical cancer after cytological evidence of human papilloma virus infection.

Authors:  H Mitchell; M Drake; G Medley
Journal:  Lancet       Date:  1986-03-15       Impact factor: 79.321

7.  Electrocoagulation diathermy for cervical dysplasia and carcinoma in situ: a 15-year survey.

Authors:  W Chanen; R M Rome
Journal:  Obstet Gynecol       Date:  1983-06       Impact factor: 7.661

8.  The management of cervical intraepithelial neoplasia by coagulation electrodiathermy.

Authors:  C B Woodman; J A Jordan; M J Mylotte; R Gustafeson; T Wade-Evans
Journal:  Br J Obstet Gynaecol       Date:  1985-07

9.  The treatment of grade 3 cervical intraepithelial neoplasia with cryotherapy: an 11-year experience.

Authors:  S C Bryson; P Lenehan; G M Lickrish
Journal:  Am J Obstet Gynecol       Date:  1985-01-15       Impact factor: 8.661

10.  Cryosurgical treatment of cervical intraepithelial neoplasia: four-year experience.

Authors:  H M Arof; M V Gerbie; J Smeltzer
Journal:  Am J Obstet Gynecol       Date:  1984-12-01       Impact factor: 8.661

View more
  3 in total

1.  Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.

Authors:  Elkanah Omenge Orang'o; Tao Liu; Astrid Christoffersen-Deb; Peter Itsura; John Oguda; Sierra Washington; David Chumba; Latha Pisharodi; Susan Cu-Uvin; Anne F Rositch
Journal:  AIDS       Date:  2017-01-14       Impact factor: 4.177

2.  Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality.

Authors:  Björn Strander; Jonas Hällgren; Pär Sparén
Journal:  BMJ       Date:  2014-01-14

3.  Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.

Authors:  Duncan C Gilbert; Katie Wakeham; Ruth E Langley; Claire L Vale
Journal:  Br J Cancer       Date:  2018-11-28       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.